JAZZ Financial Facts

Total operating expenses: 248.55M
Selling, general and administrative: 93.5M
See Full Income Statement

See Full Balance Sheet

Jazz Pharmaceuticals, Inc. (JAZZ) Earnings

  |   Expand Research on JAZZ
Next EPS Date 2/25/15 *Est. EPS Growth Rate +30.9% *Last Qtr.
Average EPS % Beat Rate -0.5% Revenue Growth Rate +32.0% *Last Qtr.
Average % Move 1-Wk after EPS -2.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/10 Q310 $0.41$0.34 +$0.07N/AN/A N/A Details
3/7/11 Q410 $0.63$0.60 +$0.03$53.4M$51.05M Details
11/5/13 Q313 $1.78$1.67 +$0.11$232.2M$227.38M = Details
8/6/13 Q213 $1.43$1.52 -$0.09$208.3M$208.71M = Details
2/26/13 Q412 $1.53$1.42 +$0.11$183.7M$183.8M = Details
7/28/11 Q211 $0.82$0.77 +$0.05$64.6M$61.86M Details
11/4/14 Q314 $2.33$2.23 +$0.10$306.6M$302.9M Details
2/27/12 Q411 $1.17$1.09 +$0.08$83.5M$80.84M = Details